Go to
JCI Insight
Citations to this article
Loka R. Penke, … , Ingrid L. Bergin, Marc Peters-Golden
Published May 7, 2018
Citation Information: J Clin Invest. 2018;128(6):2389-2405. https://doi.org/10.1172/JCI87631.
Citation Information: J Clin Invest. 2018;128(6):2389-2405. https://doi.org/10.1172/JCI87631.
Abstract
While the transcription factor forkhead box M1 (FOXM1) is well known as a proto-oncogene, its potential role in lung fibroblast activation has never been explored. Here, we show that FOXM1 is more highly expressed in fibrotic than in normal lung fibroblasts in humans and mice. FOXM1 was required not only for cell proliferation in response to mitogens, but also for myofibroblast differentiation and apoptosis resistance elicited by TGF-β. The lipid mediator PGE2, acting via cAMP signaling, was identified as an endogenous negative regulator of FOXM1. Finally, genetic deletion of FOXM1 in fibroblasts or administration of the FOXM1 inhibitor Siomycin A in a therapeutic protocol attenuated bleomycin-induced pulmonary fibrosis. Our results identify FOXM1 as a driver of lung fibroblast activation and underscore the therapeutic potential of targeting FOXM1 for pulmonary fibrosis.
Authors
Loka R. Penke, Jennifer M. Speth, Vijaya L. Dommeti, Eric S. White, Ingrid L. Bergin, Marc Peters-Golden
Total citations by year
Citation information
Citations to this article (68)
| Title and authors | Publication | Year |
|---|---|---|
|
The transcription factor ZNF469 regulates collagen production in liver fibrosis
Sebastian Steinhauser, David Estoppey, Dennis P. Buehler, Yanhua Xiong, Nicolas Pizzato, Amandine Rietsch, Fabian Wu, Nelly Leroy, Tiffany Wunderlin, Isabelle Claerr, Philipp Tropberger, Miriam Müller, Alexandra Vissieres, Lindsay M. Davison, Eric H. Farber-Eger, Quinn S. Wells, Quanhu Sheng, Sebastian Bergling, Sophia A Wild, Pierre Moulin, Jiancong Liang, Wayne J. English, D. Brandon Williams, Judith Knehr, Marc Altorfer, Alejandro Reyes, Johannes Voshol, Craig S. Mickanin, Dominic Hoepfner, Florian Nigsch, Mathias Frederiksen, Charles R. Flynn, Barna D. Fodor, Jonathan D. Brown, Christian Kolter |
JCI Insight | 2025 |
|
Distinct cAMP regulation in scleroderma lung and skin myofibroblasts governs their dedifferentiation via p38α inhibition
Baas JD, Varga J, Feghali-Bostwick C, Peters-Golden M, Fortier SM |
bioRxiv | 2025 |
|
Ablation of LRP6 in alpha‐smooth muscle actin‐expressing cells abrogates lung inflammation and fibrosis upon bleomycin‐induced lung injury
Sung E, Dozmorov MG, Song S, Aung T, Park MH, Sime PJ, Chae W |
Febs Letters | 2025 |
|
MAP kinase phosphatase-1 inhibition of p38α MAPK within lung myofibroblasts is essential for spontaneous fibrosis resolution
Sean Fortier, Natalie Walker, Loka Penke, Jared Baas, Steven Huang, Jennifer Speth, Anton Bennett, Marc Peters-Golden |
Journal of Clinical Investigation | 2024 |
|
Injury-induced FoxM1 expression in mouse kidney drives epithelial proliferation by a Cyclin F dependent mechanism
Monica Chang-Panesso, Yoshiharu Muto, Yasuhiro Yoshimura, Haojia Wu, Vladimir Kalinichenko, Benjamin Humphreys |
JCI Insight | 2024 |
|
Lipids as mediators of cancer progression and metastasis.
Vogel FCE, Chaves-Filho AB, Schulze A |
Nature cancer | 2024 |
|
GTP signaling links metabolism, DNA repair, and responses to genotoxic stress
Zhou W, Zhao Z, Lin A, Yang JZ, Xu J, Wilder-Romans K, Yang A, Li J, Solanki S, Speth JM, Walker N, Scott AJ, Wang L, Wen B, Andren A, Zhang L, Kothari AU, Yao Y, Peterson ER, Korimerla N, Werner CK, Ullrich A, Liang J, Jacobson J, Palavalasa S, O\u2019Brien AM, Elaimy AL, Ferris SP, Zhao SG, Sarkaria JN, Győrffy B, Zhang S, Al-Holou WN, Umemura Y, Morgan MA, Lawrence TS, Lyssiotis CA, Peters-Golden M, Shah YM, Wahl DR |
Cancer Discovery | 2024 |
|
The transcription factor ZNF469 regulates collagen production in liver fibrosis
Steinhauser S, Estoppey D, Buehler DP, Xiong Y, Pizzato N, Rietsch A, Wu F, Leroy N, Wunderlin T, Claerr I, Tropberger P, Müller M, Davison LM, Sheng Q, Bergling S, Wild S, Moulin P, Liang J, English WJ, Williams B, Knehr J, Altorfer M, Reyes A, Mickanin C, Hoepfner D, Nigsch F, Frederiksen M, Flynn CR, Fodor BD, Brown JD, Kolter C |
2024 | |
|
Early human fetal lung atlas reveals the temporal dynamics of epithelial cell plasticity
Quach H, Farrell S, Wu MJ, Kanagarajah K, Leung JW, Xu X, Kallurkar P, Turinsky AL, Bear CE, Ratjen F, Kalish B, Goyal S, Moraes TJ, Wong AP |
Nature Communications | 2024 |
|
Mitochondrial dysfunction is a key link involved in the pathogenesis of sick sinus syndrome: a review.
Shi X, He L, Wang Y, Wu Y, Lin D, Chen C, Yang M, Huang S |
Frontiers in cardiovascular medicine | 2024 |
|
The Reparative Effect of FOXM1 in Pulmonary Disease.
Chen T, Ni M, Wang H, Xue F, Jiang T, Wu X, Li C, Liang S, Hong L, Wu Q |
Lung | 2024 |
|
Identification of Paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in idiopathic pulmonary fibrosis
Emmeline Marchal-Duval, Méline Homps-Legrand, Antoine Froidure, Madeleine Jaillet, Mada Ghanem, Lou Deneuville, Aurélien Justet, Arnaud Maurac, Aurélie Vadel, Emilie Fortas, Aurélie Cazes, Audrey Joannes, Laura Giersch, Hervé Mal, Pierre Mordant, Carine M Mounier, Ksenija Schirduan, Martina Korfei, Andreas Guenther, Bernard Mari, Frank Jaschinski, Bruno Crestani, Arnaud A. Mailleux |
eLife | 2023 |
|
Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis
Gajjala PR, Singh P, Odayar V, Ediga HH, McCormack FX, Madala SK |
International journal of molecular sciences | 2023 |
|
Mesenchymal Cells in The Lung: Evolving Concepts and Their Role in Fibrosis
Ligresti G, Raslan AA, Hong J, Caporarello N, Confalonieri M, Huang SK |
Gene | 2023 |
|
FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
Zhang Z, Li M, Sun T, Zhang Z, Liu C |
Biomolecules | 2023 |
|
Selective BD2 Inhibitor Exerts Anti-Fibrotic Effects via BRD4/FoxM1/Plk1 Axis in Orbital Fibroblasts From Patients With Thyroid Eye Disease
Xie Y, Pan Y, Chen Q, Chen Y, Chen G, Wang M, Zeng P, Li Z, Li Z, Wang S, Yang H, Liang D |
Investigative ophthalmology & visual science | 2023 |
|
Combination Therapy as a Promising Way to Fight Oral Cancer
Silva JP, Pinto B, Monteiro L, Silva PM, Bousbaa H |
Pharmaceutics | 2023 |
|
Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways
Pokhreal D, Crestani B, Helou DG |
Cells | 2023 |
|
FOXC2-AS1/FOXC2 axis mediates matrix stiffness-induced trans-differentiation of hepatic stellate cells into fibrosis-promoting myofibroblasts
Sun L, Li Y, Wang H, Xiao X, Luo X, Yang R, Li J, Ma Y, Liu Q, Tu K, Shi Y |
International journal of biological sciences | 2023 |
|
DOCK2 Promotes Asthma Development by Eliciting Airway Epithelial–Mesenchymal Transition
Shi N, Zhang J, Chen SY |
American journal of respiratory cell and molecular biology | 2023 |
|
ADRB2 inhibition combined with antioxidant treatment alleviates lung fibrosis by attenuating TGFβ/SMAD signaling in lung fibroblasts
Wan R, Wang L, Duan Y, Zhu M, Li W, Zhao M, Yuan H, Xu K, Li Z, Zhang X, Yu G |
Cell Death Discovery | 2023 |
|
Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1
Xu R, Lee YJ, Kim CH, Min GH, Kim YB, Park JW, Kim DH, Kim JH, Yim H |
Journal of experimental & clinical cancer research : CR | 2023 |
|
Inhibiting stromal Class I HDACs curbs pancreatic cancer progression.
Liang G, Oh TG, Hah N, Tiriac H, Shi Y, Truitt ML, Antal CE, Atkins AR, Li Y, Fraser C, Ng S, Pinto AFM, Nelson DC, Estepa G, Bashi S, Banayo E, Dai Y, Liddle C, Yu RT, Hunter T, Engle DD, Han H, Von Hoff DD, Downes M, Evans RM |
Nature Communications | 2023 |
|
Thrombocyte-derived Dickkopf1 promotes macrophage polarization in the Bleomycin-induced lung injury model
Sung EA, Park MH, Song S, Alanya H, Henegariu O, Liu J, Erson-Omay EZ, Sime PJ, Chae WJ |
Frontiers in immunology | 2023 |
|
Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression
Liang L, Cai T, Li X, An J, Yu S, Zhang Y, Guo F, Wei F, He J, Xie K, Jiang T |
Genes & Diseases | 2023 |
|
Transcriptional analysis of lung fibroblasts identifies PIM1 signaling as a driver of aging-associated persistent fibrosis
Tho X Pham, Jisu Lee, Jiazhen Guan, Nunzia Caporarello, Jeffrey Meridew, Dakota Jones, Qi Tan, Steven K Huang, Daniel Tschumperlin, Giovanni Ligresti |
JCI Insight | 2022 |
|
Kruppel-like factor 4 as a therapeutically tractable brake on lung fibroblast activation which promotes resolution of pulmonary fibrosis
Loka Penke, Jennifer Speth, Steven Huang, Jared Baas, Marc Peters-Golden |
JCI Insight | 2022 |
|
The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review
G Stella, V DAgnano, D Piloni, L Saracino, S Lettieri, F Mariani, A Lancia, C Bortolotto, P Rinaldi, F Falanga, C Primiceri, A Corsico, A Bianco |
Translational Lung Cancer Research | 2022 |
|
Wnt Site Signaling Inhibitor Secreted Frizzled‐Related Protein 3 Protects Mitral Valve Endothelium From Myocardial Infarction–Induced Endothelial‐to‐Mesenchymal Transition
Z Alvandi, Y Nagata, L Passos, A Gheinani, J Guerrero, J WylieSears, D Romero, B Morris, S Sullivan, K Yaghoubian, A Alvandi, R Adam, E Aikawa, R Levine, J Bischoff |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2022 |
|
Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review
Y Yan, J Fu, R Kowalchuk, C Wright, R Zhang, X Li, Y Xu |
Translational Lung Cancer Research | 2022 |
|
ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1
W Sun, Y Li, D Ma, Y Liu, Q Xu, D Cheng, G Li, C Ni |
Cellular & Molecular Biology Letters | 2022 |
|
Distinctive molecular features of regenerative stem cells in the damaged male germline
H La, J Liao, J Legrand, F Rossello, A Chan, V Vaghjiani, J Cain, A Papa, T Lee, R Hobbs |
Nature Communications | 2022 |
|
Metabolic reprogramming of pulmonary fibrosis
Li J, Zhai X, Sun X, Cao S, Yuan Q, Wang J |
Frontiers in pharmacology | 2022 |
|
Identification of prognostic values of the transcription factor-CpG-gene triplets in lung adenocarcinoma: A narrative review.
Lian D, Lian L, Zeng D, Zhang M, Chen M, Liu Y, Ying W, Zhou S |
Medicine | 2022 |
|
PVECs‐Derived Exosomal microRNAs Regulate PASMCs via FoxM1 Signaling in IUGR‐induced Pulmonary Hypertension
Luo X, Hang C, Zhang Z, Le K, Ying Y, Lv Y, Yan L, Huang Y, Ye L, Xu X, Zhong Y, Du L |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2022 |
|
Epigenetic regulation of IPF fibroblast phenotype by glutaminolysis.
Xiang Z, Bai L, Zhou JQ, Cevallos RR, Sanders JR, Liu G, Bernard K, Sanders YY |
Molecular Metabolism | 2022 |
|
Myofibroblast de-differentiation proceeds via distinct transcriptomic and phenotypic transitions
Sean Fortier, Loka R. Penke, Dana M. King, Tho X Pham, Giovanni Ligresti, Marc Peters-Golden |
JCI Insight | 2021 |
|
Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis
Prathibha R. Gajjala, Rajesh K. Kasam, Divyalakshmi Soundararajan, Debora Sinner, Steven K Huang, Anil G. Jegga, Satish K. Madala |
JCI Insight | 2021 |
|
The epidermal growth factor receptor axis and kidney fibrosis
RC Harris |
Current Opinion in Nephrology and Hypertension | 2021 |
|
Human umbilical cord mesenchymal stromal cells attenuate pulmonary fibrosis via regulatory T cell through interaction with macrophage
Z Tang, J Gao, J Wu, G Zeng, Y Liao, Z Song, X Liang, J Hu, Y Hu, M Liu, N Li |
Stem Cell Research & Therapy | 2021 |
|
Extracellular HSP90α Interacts With ER Stress to Promote Fibroblasts Activation Through PI3K/AKT Pathway in Pulmonary Fibrosis
J Zhang, W Zhong, Y Liu, W Chen, Y Lu, Z Zeng, Y Qiao, H Huang, X Wan, W Li, X Meng, F Zou, S Cai, H Dong |
Frontiers in pharmacology | 2021 |
|
MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
X Sun, M Zhu, X Chen, X Jiang |
Frontiers in pharmacology | 2021 |
|
Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy
J Hou, Q Ji, J Ji, S Ju, C Xu, X Yong, X Xu, M Muddassir, X Chen, J Xie, X Han |
Theranostics | 2021 |
|
A Role for Polo-Like Kinase 4 in Vascular Fibroblast Cell-Type Transition
J Li, G Urabe, Y Huang, M Zhang, B Wang, L Marcho, H Shen, KC Kent, LW Guo |
JACC: Basic to Translational Science | 2021 |
|
The Roles of Various Prostaglandins in Fibrosis: A Review
K Li, J Zhao, M Wang, L Niu, Y Wang, Y Li, Y Zheng |
Biomolecules | 2021 |
|
Transcriptome Analysis of the Anti-TGFβ Effect of Schisandra chinensis Fruit Extract and Schisandrin B in A7r5 Vascular Smooth Muscle Cells
S Lee, JN Chun, HJ Lee, HH Park, I So, JH Jeon, EJ Park |
Life Sciences | 2021 |
|
PRMT7 targets of Foxm1 controls alveolar myofibroblast proliferation and differentiation during alveologenesis
H He, J Chen, J Zhao, P Zhang, Y Qiao, H Wan, J Wang, M Mei, S Bao, Q Li |
Cell Death and Disease | 2021 |
|
Distinct roles of KLF4 in mesenchymal cell subtypes during lung fibrogenesis
RR Chandran, Y Xie, E Gallardo-Vara, T Adams, R Garcia-Milian, I Kabir, AQ Sheikh, N Kaminski, KA Martin, EL Herzog, DM Greif |
Nature Communications | 2021 |
|
CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism
JP Guégan, J Pollet, C Ginestier, E Charafe-Jauffret, ME Peter, P Legembre |
iScience | 2021 |
|
Bortezomib Inhibits Lung Fibrosis and Fibroblast Activation Without Proteasome Inhibition
L Penke, J Speth, S Wettlaufer, C Draijer, M Peters-Golden |
American journal of respiratory cell and molecular biology | 2021 |
|
Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway
C Goda, D Balli, M Black, D Milewski, T Le, V Ustiyan, X Ren, VV Kalinichenko, TV Kalin, GS Barsh |
PLoS genetics | 2020 |
|
Transcriptional regulation of the IL-13Rα2 gene in human lung fibroblasts
LR Penke, H Ouchi, JM Speth, N Lugogo, YJ Huang, SK Huang, M Peters-Golden |
Scientific Reports | 2020 |
|
The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity
F Li, X Xu, J Geng, X Wan, H Dai |
Experimental and therapeutic medicine | 2020 |
|
Role of FOXM1 in vascular smooth muscle cell survival and neointima formation following vascular injury
S Franco, A Stranz, F Ljumani, G Urabe, M Chaudhary, D Stewart, VS Pilli, M Kelly, D Yamanouchi, KC Kent, B Liu |
Heliyon | 2020 |
|
Transcriptomic Evaluation of Pulmonary Fibrosis-Related Genes: Utilization of Transgenic Mice with Modifying p38 Signal in the Lungs
S Matsuda, JD Kim, F Sugiyama, Y Matsuo, J Ishida, K Murata, K Nakamura, K Namiki, T Sudo, T Kuwaki, M Hatano, K Tatsumi, A Fukamizu, Y Kasuya |
International journal of molecular sciences | 2020 |
|
Low let‐7d exosomes from pulmonary vascular endothelial cells drive lung pericyte fibrosis through the TGFβRI/FoxM1/Smad/β‐catenin pathway
H Xie, YM Gao, YC Zhang, MW Jia, F Peng, QH Meng, YC Wang |
Journal of Cellular and Molecular Medicine | 2020 |
|
A FOX-like Mechanism Regulating Lung Fibroblasts: Are We Getting There?
SS Pullamsetti, A Günther |
American journal of respiratory cell and molecular biology | 2020 |
|
EGF receptor–mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signaling
M Chiusa, W Hu, J Zienkiewicz, X Chen, MZ Zhang, RC Harris, RM Vanacore, JA Bentz, G Remuzzi, A Benigni, AB Fogo, W Luo, S Mili, MH Wilson, R Zent, J Hawiger, A Pozzi |
The Journal of Cell Biology | 2020 |
|
Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation
B Ballester, J Milara, J Cortijo |
Oncotarget | 2020 |
|
FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition
A Diab, H Gem, J Swanger, HY Kim, K Smith, G Zou, S Raju, M Kao, M Fitzgibbon, KR Loeb, CP Rodriguez, E Méndez, DA Galloway, JM Sidorova, BE Clurman |
Proceedings of the National Academy of Sciences | 2020 |
|
Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer
S Ros, AJ Wright, P D'Santos, D Hu, RL Hesketh, Y Lubling, D Georgopoulou, G Lerda, DL Couturier, P Razavi, R Pelossof, AS Batra, E Mannion, DY Lewis, A Martin, RD Baird, M Oliveira, LW de Boo, SC Linn, M Scaltriti, OM Rueda, A Bruna, C Caldas, KM Brindle |
Cancer Cell | 2020 |
|
The multifaceted roles of FOXM1 in pulmonary disease
Y Li, F Wu, Q Tan, M Guo, P Ma, X Wang, S Zhang, J Xu, P Luo, Y Jin |
Cell Communication and Signaling | 2019 |
|
Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice
T Kurahashi, Y Yoshida, S Ogura, M Egawa, K Furuta, H Hikita, T Kodama, R Sakamori, S Kiso, Y Kamada, IC Wang, H Eguchi, E Morii, Y Doki, M Mori, VV Kalinichenko, T Tatsumi, T Takehara |
CMGH Cellular and Molecular Gastroenterology and Hepatology | 2019 |
|
Molecular determinants of mesenchymal cell activation in fibroproliferative diseases
LR Penke, M Peters-Golden |
Cellular and Molecular Life Sciences | 2019 |
|
Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP
L Sun, Y Wang, L Wang, B Yao, T Chen, Q Li, Z Liu, R Liu, Y Niu, T Song, Q Liu, K Tu |
Journal of Experimental & Clinical Cancer Research | 2019 |
|
Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter: SONG et al
S Song, R Zhang, W Cao, G Fang, Y Yu, Y Wan, C Wang, Y Li, Q Wang |
Journal of Cellular Physiology | 2018 |
|
New therapeutics based on emerging concepts in pulmonary fibrosis
V Sontake, PR Gajjala, RK Kasam, SK Madala |
Expert Opinion on Therapeutic Targets | 2018 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)